FDA’s decision regarding Contrave® and Saxenda®

Last week, the U.S. Food and Drug Administration (FDA) announced its decisions regarding two obesity treatment medications: Contrave® and Saxenda®. Contrave was approved and it appears Saxenda will be in the near future.

Leave a reply